• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 05/01/15

    • 30-Day SEC Yield1

      -0.09%
    • Total Net Assets

      $757.7M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/18/2015
  • Portfolio Composition (%)
    as of 05/01/15

    • % of Net Assets
    • Stocks

      100.12
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.12
  • Download All HoldingsAll Holdings (%) as of 05/01/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    1,072,860
    112,661,02914.87
    Amgen Inc
    AMGN US
    576,997
    92,527,23912.21
    Celgene Corp
    CELG US
    712,857
    78,806,34110.40
    Biogen Idec Inc
    BIIB US
    157,263
    60,738,1168.02
    Regeneron Pharmaceuticals Inc
    REGN US
    89,581
    42,206,9845.57
    Vertex Pharmaceuticals Inc
    VRTX US
    279,098
    35,054,7094.63
    Biomarin Pharmaceutical Inc
    BMRN US
    299,071
    34,668,3104.58
    Illumina Inc
    ILMN US
    179,928
    34,407,6314.54
    Alexion Pharmaceuticals Inc
    ALXN US
    191,425
    33,020,8134.36
    Medivation Inc
    MDVN US
    242,427
    30,402,7704.01
    Incyte Corp Ltd
    INCY US
    308,846
    30,353,3854.01
    Pharmacyclics Inc
    PCYC US
    113,417
    28,865,7613.81
    Alnylam Pharmaceuticals Inc
    ALNY US
    185,854
    19,865,9342.62
    United Therapeutics Corp
    UTHR US
    116,043
    19,834,0702.62
    Qiagen Nv
    QGEN US
    678,613
    16,327,4292.15
    Isis Pharmaceuticals Inc
    ISIS US
    241,321
    14,054,5351.85
    Alkermes Plc
    ALKS US
    226,592
    13,391,5871.77
    Grifols Sa
    GRFS US
    395,052
    12,586,3571.66
    Puma Biotechnology Inc
    PBYI US
    48,844
    9,195,3711.21
    Cepheid Inc
    CPHD US
    155,417
    8,832,3481.17
    Charles River Laboratories Internationa
    CRL US
    123,116
    8,694,4521.15
    Intercept Pharmaceuticals Inc
    ICPT US
    30,309
    7,728,4921.02
    Seattle Genetics Inc
    SGEN US
    161,704
    5,502,7870.73
    Myriad Genetics Inc
    MYGN US
    142,401
    4,867,2660.64
    Mannkind Corp
    MNKD US
    969,732
    4,053,4800.53
    Other/Cash
    -911,978-0.12
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.